跳至主要内容
临床试验/NCT02665390
NCT02665390Unknown不适用

Percutaneous Cryoablation for the Treatment of Medically Inoperable Peripheral Lung Cancer

Shanghai Chest Hospital0 个研究点目标入组 30 人开始时间: 2016年2月最近更新:
适应症

试验速览

阶段
不适用
入组人数
30
主要终点
PFS

研究概览

简要总结

This study is focus on percutaneous cryoablation,which was for the treatment of medically inoperable Peripheral lung cancer.The patients who were agreed to attend the study will accept the operation. After the operations,they will follow up according to the plan.

详细描述

The patients who were agreed to attend the study conclude early stage lung cancer and solitary metastatic lung cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • medically inoperable peripheral lung cancer Diameter no more than 3cm

排除标准

  • Refusal of participation
  • tendency to bleed to that can't receive percutaneous cryoablation.
  • Severe cardiopulmonary dysfunction and other indications that can't receive percutaneous cryoablation.

结局指标

主要结局

PFS

时间窗: 2 years

次要结局

  • OS(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jiayuan Sun

Director, Endoscope Center, Shanghai Chest Hospita

Shanghai Chest Hospital

相似试验